Safety and Efficacy of Once Daily Topical Treatment With LEO 90100 Aerosol Foam in Adolescent Subjects With Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions
Psoriasis Vulgaris
Interventions
DRUG

LEO 90100

Trial Locations (9)

6525

UMC St Radboud, Nijmegen

10012

Greenwich Village Dermatology, New York

10155

Skin Speciality Dermatology, New York

94304

Lucile Packard Children's Hospital at Stanford, Palo Alto

95403-2805

Redwood Family Dermatology, Santa Rosa

48059-3526

Hamzavi Dermatology, Fort Gratiot

75230-5808

Dermatology Treatment and Research Center PA, Dallas

40-123

MULTIKLINIKA SALUTE Sp zo.o., Katowice

030303

Spitalul Clinic de Boli Infectioase si Tropicale, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LEO Pharma

INDUSTRY